Small Molecule Drugs in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBDs), mainly represented by Crohn’s disease (CD) and Ulcerative Colitis (UC), are chronic disorders with an unclear pathogenesis. This incurable and iterative intestinal mucosal inflammation requires the life-long use of anti-inflammatory drugs to prevent flares or rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Ghezala, Inès, Charkaoui, Maëva, Michiels, Christophe, Bardou, Marc, Luu, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308576/
https://www.ncbi.nlm.nih.gov/pubmed/34209234
http://dx.doi.org/10.3390/ph14070637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308576/
https://www.ncbi.nlm.nih.gov/pubmed/34209234
http://dx.doi.org/10.3390/ph14070637

Ejemplares similares